Addex Therapeutics Ltd (SWX:ADXN)

Addex Therapeutics Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.94	1.64	3.34	3.87	6.96	20.48
Cash & Short-Term Investments	0.94	1.64	3.34	3.87	6.96	20.48
Cash Growth	-66.90%	-50.97%	-13.55%	-44.44%	-66.04%	9.57%
Receivables	0.03	0.02	0.02	0.15	0.6	0.32
Prepaid Expenses	0.22	0.02	0.17	0.22	0.27	1.12
Other Current Assets	0	0.01	0.01	0	0	0.02
Total Current Assets	1.19	1.68	3.54	4.23	7.83	21.94
Property, Plant & Equipment	0.1	0.03	0.04	0.35	0.4	0.54
Long-Term Investments	2.9	4.13	7.09	-	-	-
Other Long-Term Assets	0.56	0.52	0.01	0.05	0.05	0.06
Total Assets	4.76	6.36	10.68	4.64	8.28	22.54

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.63	0.6	0.25	0.98	1.28	1.79
Accrued Expenses	0.46	0.59	0.54	1.4	1.72	2.06
Current Portion of Leases	0.08	0.01	0.01	0.27	0.29	0.29
Current Unearned Revenue	-	-	-	0.23	-	-
Total Current Liabilities	1.22	1.2	0.8	2.89	3.28	4.13
Long-Term Leases	0.03	0.03	0.03	0.07	0.09	0.19
Long-Term Unearned Revenue	-	-	-	0.09	-	-
Pension & Post-Retirement Benefits	0.23	0.37	0.16	0.44	-	1.28
Total Liabilities	1.47	1.6	1	3.5	3.37	5.61

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	2.19	2.19	1.84	1.84	1.15	49.27
Additional Paid-In Capital	267.36	267.31	266.38	266.19	269.51	283.98
Retained Earnings	-361.8	-360.09	-353.36	-360.42	-349.86	-329.06
Treasury Stock	-1	-1.01	-0.87	-0.91	-6.28	-11.7
Comprehensive Income & Other	96.54	96.38	95.68	94.44	90.39	24.44
Shareholders' Equity	3.29	4.77	9.68	1.15	4.91	16.93
Total Liabilities & Equity	4.76	6.36	10.68	4.64	8.28	22.54

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.1	0.03	0.04	0.34	0.37	0.48
Net Cash (Debt)	0.83	1.6	3.3	3.52	6.58	20
Net Cash Growth	-70.10%	-51.39%	-6.29%	-46.52%	-67.08%	10.34%
Net Cash Per Share	0.01	0.01	0.03	0.05	0.15	0.59
Filing Date Shares Outstanding	119.32	117.93	98.34	128.26	80.88	37.9
Total Common Shares Outstanding	119.32	117.93	98.34	125.2	77.13	37.9
Working Capital	-0.03	0.48	2.74	1.34	4.55	17.81
Book Value Per Share	0.03	0.04	0.10	0.01	0.06	0.45
Tangible Book Value	3.29	4.77	9.68	1.15	4.91	16.93
Tangible Book Value Per Share	0.03	0.04	0.10	0.01	0.06	0.45
Machinery	-	0	0.08	1.73	1.72	1.72

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 1, 2026

Data Sources Report a data error